Progression-Free Survival with Fulvestrant 500 mg and Alternative Endocrine Therapies as Second-Line Treatment for Advanced Breast Cancer: A Network Meta-Analysis with Parametric Survival Models
Autor: | Cope, Shannon, Ouwens, Mario J.N.M., Jansen, Jeroen P. ⁎, Schmid, Peter |
---|---|
Zdroj: | In Value in Health March-April 2013 16(2):403-417 |
Databáze: | ScienceDirect |
Externí odkaz: |